AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05522933 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 4 weekly musculoskeletal health promotion workshops with stretching and muscle-strengthening exercise
Description: The modified online multidimensional musculoskeletal health promotion program will consist of 4 weekly workshops for 90-minute each for a group size of 8-12 participants. The topics of the workshop are: (1) exercise and health \& work; (2) prevention of musculoskeletal problems; (3) musculoskeletal health and traditional Chinese medicine; and (4) mental health and community resources. Each workshop will consist of stretching and muscle strengthening exercises (30 minutes), a health education topic (about 45 minutes), and a question-and-answer period (about 15 minutes).
Study NCT06368466 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iStatis HBsAg Test
Description: capillary (fingerstick) blood, EDTA venous whole blood, serum and plasma samples are tested on the iStatis HBsAg Test
Study NCT04816617 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention
Description: The whole exercise lasts for 12 months, consisted of 6-month supervised exercise and 6-month maintenance period. It is moderate -intensity exercise (60-80% Maximum heart rate), each time last for 30 mins (plus 10-minutes for warm-up and cool-down), 3-4 times a week, for the first six months, which will be supervised in person by physical educators and/or physical professionals. In the maintenance period, participants are asked to exercise at the same intensity and frequency, but will not be supervised in person by physical educators/professionals. They will receive reminder on a weekly basis and their physical activities be recorded by accelerometer. Types of exercise will be chosen according to individual school's facility and feasibility, including jogging, fast walking, badminton, running, football etc.
Study NCT04816617 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Psycho-education
Description: It consists of 6 sections of psycho-education, with topics covering mood regulations and mental well-being. Approximately 1 section in every two months.
Study NCT05527171 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality Mindfulness Meditation
Description: Participants will be immersed in a virtual environment of their choosing. While in the virtual environment, participants will follow a guided mindfulness meditation script. Participants will complete the intervention 3 times a week over the course of 8-weeks.
Study NCT05527171 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Virtual Reality Sham
Description: Participants will be immersed in a virtual environment of their choosing, such as at a beach, forest, or lake.
Study NCT05590793 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triptorelin pamoate (embonate) salt
Description: Triptorelin pamoate 22.5 mg (6-month formulation), i.m. injection, single dose on Day 1.
Study NCT06530550 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PI3K inhibitor
Description: Linperlisib 80mg QD orally, or Duvelisib 25mg BID orally, with a 28-day cycle. Efficacy will be evaluated once per cycle during the first year, and once every two cycles thereafter. Treatment will continue for up to 24 cycles, or until disease progression, lack of response within the first 6 cycles, or the occurrence of intolerable toxicity, whichever occurs first
Study NCT06122792 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: preemptive TIPS
Description: The TIPS procedure should be performed within 72 hours after the initial endoscopic examination or treatment. An 8 mm Viatorr stent will be used for TIPS establishment. The aim will be to reduce the portal pressure gradient below 12 mm Hg. Embolization, either with coils or glue, can be performed, if it is felt necessary, especially in patients where portography shows the filling of large portosystemic collaterals feeding the varices. After TIPS, anticoagulation will not be used as a rule but is allowed if the attending physician thinks that it is warranted.
Study NCT06122792 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: standard second prophylaxis
Description: Patients will receive vasoactive drugs up to 5 days; then a non-selective beta-blocker (carvedilol) will be started with an initial dose of 6.25 mg, the dose of propranolol will be increased to 12.5 mg.~The second elective session of endoscopic injection of tissue adhesives will be performed within the first 28 days after the initial endoscopic treatment. The following sessions will be performed at 28 +/- 3 days intervals until variceal eradication. Once eradication is achieved, endoscopic monitoring will be performed every 6 months. If varices reappear, new endoscopic injection of tissue adhesives will be performed.
Study NCT06354036 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: the Transhiatal Tunnel Valvuloplasty technique
Description: The ThTV esophagogastrostomy procedure involved placing a lengthy gastric tube into the lower mediastinum, firmly bound to the esophagus.
Study NCT04900233 — intervention group
Intervention type: OTHER
Intervention: surgery
Description: emergency surgery
Study NCT05165511 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PBT-EF
Description: PBT-EF will be delivered to parents only. Parents will be taught general behavioral weight loss skills to apply to their child and themselves including decreasing caloric intake and increasing physical activity, self-monitoring, and goal setting. Additionally, parents will learn compensatory strategies surrounding organization, habit learning, planning, and problem-solving to generalize FBT skills to real-world behaviors (e.g., self-monitoring of food intake). Each session will include interactive exercises to help train an aspect of EF. Skills taught will be presented to be practiced with real-world applications.
Study NCT03773328 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CK0801
Description: CK0801 (Cord blood-derived T-regulatory cells)
Study NCT05618483 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Nasal Spray
Description: The nasal spray is made of xylitol and grapefruit seed extract. The spray is antiviral, but there is no data of its clinical efficacy against Covid-19.
Study NCT05618483 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nasal Spray
Description: The nasal spray is made of xylitol and grapefruit seed extract. The spray is antiviral, but there is no data of its clinical efficacy against Covid-19.
Study NCT05493852 — intervention group
Intervention type: DEVICE
Intervention: FARAPULSE Pulsed Field Ablation System
Description: Patients diagnosed as paroxysmal atrial fibrillation with indication of ablation will be treated by FARAPULSE Pulsed Field Ablation System.
Study NCT06356285 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Presentation of Antimicrobial Resistance
Description: Participants will be presented with a poster containing information about antibiotics, each intervention poster will have a different name at the top, representing a new way to frame antimicrobial resistance.
Study NCT05568888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BE1116
Description: 4-Factor Prothrombin Complex administered by intravenous (IV) infusion
Study NCT05568888 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered by IV infusion
Study NCT04511013 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Binimetinib
Description: Given PO
Study NCT04511013 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Encorafenib
Description: Given PO
Study NCT04511013 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Given IV
Study NCT04782115 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: intravitreal injection of RC28-E
Description: a chimric decoy receptor trap fusion protein by dual blockage of VEGF and FGF
Study NCT04511013 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV
Study NCT04888793 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Serologic immune response evaluation
Description: Detection of total and neutralizing antibodies against SARS-CoV-2
Study NCT04782115 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Conbercept
Description: KH902(Conbercept）
Study NCT05089513 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robotic surgery
Description: Robotoc surgery (Da Vinci) in both donor and recipient
Study NCT04698395 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE)
Description: motor learning-based, intensive therapy for children with cerebral palsy
Study NCT04698395 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Regular care
Description: customary or usual care given to any infant/toddler with cerebral palsy
Study NCT05574582 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Graft reconstruction and internal fixation with compression screw
Description: Patients suffering from scaphoid nonunion are treated surgically by debridement, graft reconstruction and internal fixation with compression screw
Study NCT05574582 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Graft reconstruction and internal fixation with compression screw
Description: Patients suffering from scaphoid nonunion are treated surgically by debridement, graft reconstruction and internal fixation with compression screw
Study NCT04687137 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-743 300 mg
Description: TAK-743 300 mg, subcutaneous injection every 2 or 4 weeks
Study NCT05944848 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1 mg CL-197 capsules
Description: Single oral dose of 1 mg CL-197 capsules or CL-197 placebo administered following ≥10 hour fast
Study NCT05944848 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10 mg CL-197 capsules or CL-197 placebo
Description: Single oral dose of 10 mg CL-197 capsules or CL-197 placebo administered following ≥10 hour fast
Study NCT05944848 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 30 mg CL-197 capsules or CL-197 placebo
Description: Single oral dose of 30 mg CL-197 capsules or CL-197 placebo administered following ≥10 hour fast
Study NCT05944848 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 60 mg CL-197 capsules or CL-197 placebo
Description: Single oral dose of 60 mg CL-197 capsules or CL-197 placebo administered following ≥10 hour fast
Study NCT05944848 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 100 mg CL-197 capsules or CL-197 placebo
Description: Single oral dose of 100 mg CL-197 capsules or CL-197 placebo administered following ≥10 hour fast
Study NCT04927299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Losartan/Chlorthalidone in fixed dose
Description: 1 tablet, once a day of 50 mg/12.5 or 100 mg/ 25 mg
Study NCT04927299 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Losartan + hydrochlorothiazide in fixed dose
Description: 1 tablet, once a day of 50 mg/12.5 or 100 mg/ 25 mg
Study NCT04564183 — intervention group
Intervention type: OTHER
Intervention: Sample collection
Description: Blood, Urine, Nail, Hair, Saliva, optional Stool
Study NCT04564183 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: SF-36, Food Frequency, Pulmonary Fibrosis Study questionnaire, COVID questionnaire
Study NCT04564183 — intervention group
Intervention type: RADIATION
Intervention: High resolution CT scan of the chest
Description: Upon enrollment, all participants will undergo single prone volumetric thoracic chest CT scan. This will be performed at full inspiration using a 64-slice CT scanner.
Study NCT04564183 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Pulmonary Function Test
Description: All recruited participants will undergo a pre-bronchodilator spirometry test and a lung diffusion capacity test, both in accordance with ATS guidelines. Exercise capacity (maximum physical exertion) will be assessed by performing a 6-minute walk test, also according to ATS guidelines.
Study NCT05305183 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Minodronate Tablets and Alendronate Sodium Tablets-matching placebo;Alendronate Sodium Tablets and Minodronate Tablets -matching placebo
Description: all subjects will receive Calcium Carbonate and Vitamin D3 Tablets as basic medication.
Study NCT05305183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minodronate Tablets and Alendronate Sodium Tablets-matching placebo;Alendronate Sodium Tablets and Minodronate Tablets -matching placebo
Description: all subjects will receive Calcium Carbonate and Vitamin D3 Tablets as basic medication.
Study NCT05049889 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Terrestrial exercise
Description: At visit 1 (Day 0), an exercise test will be performed (maximal incremental test), followed by a 30-minute submaximal exercise at constant load.~During this exercise, continuous data collection will be performed:~* Continuous 12-lead electrocardiogram~* Continuous monitoring of blood pressure and ventilation.
Study NCT05533593 — intervention group
Intervention type: DRUG
Intervention: Aminoglycoside
Description: Inpatients using aminoglycoside
Study NCT06295874 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Effect of aromatherapy massage on vital signs, pain, anxiety and comfort level
Description: The study applied a mixture of lavender, thyme and eucalyptus oil (5 drops of lavender oil, 4 drops of thyme oil, 3 drops of eucalyptus oil and 20 ml of almond oil in 20 ml) to patients who were monitored in intensive care on high-flow and oxygen, for three days. It was conducted as a randomized controlled single-blind study to evaluate the effects of aromatherapy massage applied twice a day for a total of 30 minutes on some physiological parameters, pain, anxiety and comfort levels.
Study NCT06295874 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Effect of aromatherapy massage on vital signs, pain, anxiety and comfort level
Description: The study applied a mixture of lavender, thyme and eucalyptus oil (5 drops of lavender oil, 4 drops of thyme oil, 3 drops of eucalyptus oil and 20 ml of almond oil in 20 ml) to patients who were monitored in intensive care on high-flow and oxygen, for three days. It was conducted as a randomized controlled single-blind study to evaluate the effects of aromatherapy massage applied twice a day for a total of 30 minutes on some physiological parameters, pain, anxiety and comfort levels.
Study NCT05182060 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transition Intervention
Description: We will implement a bundle of care transition safety strategies with the assistance of home care coordinators at the study site and corresponding home health provider teams (nurses, rehabilitation therapists).~Home care coordinators will approach patients at the study site being referred for home health and provide resources to assist them with preparing for their transition home. These resources include a link to a video about home health services, a caregiver assessment, a care task role assignment sheet, and a shopping list. The study team will contact the older adult and caregiver by telephone within 48 hours of the home visit to confirm eligibility, explain the study, obtain consent for participation, and ask them to complete the the Hospital-to-Home Health Transition Quality Index (H3TQ) over the phone. Home health providers in the home will also complete the H3TQ.
Study NCT06578221 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kegel Pelvic Floor Muscle Exercise Group
Description: After the surgery, the patients will be taken to the clinic room in a supine position and the researcher will perform the Kegel pelvic floor muscle exercises three times at the 1st, 4th and 7th hours within the first 8 hours after the patients are taken to the clinic room.
Study NCT06578481 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercises
Description: Individuals in the first group underwent cervical stabilization (CS) exercises and additional scapular and lumbopelvic stabilization (SLPS) exercises three times a week for 6 weeks. The second group was treated with only CS exercises for the same period. In addition, stretching exercises and a 20-minute hot pack were applied to the muscles around the neck of all patients.
Study NCT06578481 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercises
Description: Individuals in the first group underwent cervical stabilization (CS) exercises and additional scapular and lumbopelvic stabilization (SLPS) exercises three times a week for 6 weeks. The second group was treated with only CS exercises for the same period. In addition, stretching exercises and a 20-minute hot pack were applied to the muscles around the neck of all patients.
Study NCT05884385 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simulated exercises
Description: as detailed in arm description
Study NCT05884385 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mental Visualisation
Description: as detailed in arm description
Study NCT05880875 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reflective Supervision Enhancement
Description: The Reflective Supervision enhancement is a professional development series designed to train and support directors and education coordinators supervising state pre-kindergarten classrooms in using a reflective supervision approach with their staff.
Study NCT06155955 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Emicizumab, HEMLIBRA®
Description: low dose
Study NCT05049889 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Swimming exercise
Description: At visit 2 (Day 7), the subjects will perform a swimming exercise in the experimental pool equipped with a turbine to create a counter-current. The water speed will be constant (4 min per 100 m, i.e. 1.5 km/h). The duration of the exercise will be 30 minutes. Each diver will breathe with the help of a snorkel.~During this exercise, continuous data collection will be performed:~* Continuous 12-lead electrocardiogram~* Continuous monitoring of blood pressure and ventilation.
Study NCT05049889 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transthoracic cardiac ultrasound
Description: The participants will have a transthoracic cardiac ultrasound to measure the dilatations of the cardiac cavities at visit 1 and 2.
Study NCT05049889 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transthoracic pulmonary ultrasound
Description: The participants will have a transthoracic pulmonary ultrasound to quantify the presence of signs of pulmonary vascular overload (comet tails) at visit 1 and 2.
Study NCT05049889 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Blood collection
Description: Several blood samples will be collected at visit 1 and 2.
Study NCT06270849 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: The questionnaire to assess severity of LUTS in women.
Study NCT06295458 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: David Delight Plus Device
Description: Flicker exposure via a light and sound device-based stimulation-provided sensory stimulation device. The DAVID Delight Plus device consists of light-emitting goggles and sound-emitting headphones that are turned on and off with a repetition rate of 40 Hz connected to a controller operated by the participant or study partner (if the participant elects to have an optional study partner). At the baseline visit, light and sound intensity levels (auditory: 0-80 dBA, visual: 0-1400 lux) will be programmed into each participant's controller based on their unique response to tolerance and EEG entrainment testing which occurred at screening. The participant may not detect gamma-flicker frequency.
Study NCT06295458 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Therapy
Description: Sham therapy will be provided in the same manner as the flicker light. The difference is that it will be a constant light and sound from the same device instead of the 40hz light treatment and sound.
Study NCT05535777 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced texts with Callback by a Person
Description: Enhanced texts - Callback by a person: Patient randomized to this study arm will receive a phone call back by a call center agent if they press 1 in response to a question on the original text message. The call center agent's job is to schedule patients for clinical visits. These call center agents will be trained by our faculty and staff and will have the usual HIPAA and other patient confidentiality training.
Study NCT05535777 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Bidirectional Texts
Description: Patients randomized to this study arm will receive a text message from a call center agent if they press 1 in response to a question on the original text message. The bidirectional texts will have an agent who can answer questions and schedule an appointment through text message back-and-forth conversations with the patient.
Study NCT06340334 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tegoprazan-amoxicillin dual therapy
Description: A total of 600 Hp-positive patients who had not received Hp eradication therapy before or had had Hp eradication in the early stage but had not undergone eradication therapy in the past six months were randomly divided into two groups: group A subjects received Tegoprazan 50 mg, bid + amoxicillin 1000 mg, tid; Group B subjects received Tegoprazan 50 mg, bid + amoxicillin 1000 mg, bid + furazolidone 100 mg, bid + colloidal pectin bismuth 300 mg, bid. The duration of treatment is 14 days. The eradication rate, adverse reactions, and compliance of the two groups were compared.